Skip to content

Exploring the clinical efficacy and potential mechanism of ultrasound-guided small needle knife treatment for knee arthritis based on the theory of "bone flesh matching"

Exploring the clinical efficacy and potential mechanism of ultrasound-guided small needle knife treatment for knee arthritis based on the theory of "bone flesh matching"

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000182
Enrollment
Unknown
Registered
2024-08-07
Start date
2024-05-31
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Observation group:Ultrasound guided small needle knife release combined with resistance movement. The above operation is performed once a week, with 4 weeks as one course of treatment.
Control group:Take 0.2 g/tablet of Celecoxib capsules orally, 1 tablet each time, once daily, for 4 consecutive weeks. Joint resistance exercise, 3 groups per day, for 4 consecutive weeks.

Sponsors

Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Meets the diagnostic criteria of traditional Chinese and Western medicine for knee osteoarthritis, belonging to the attack and remission stages; 2) Age range: 45-75 years old; 3) Patients with K-L staging of stages I, II, and III; 4) Patients with knee joint bone marrow edema under magnetic resonance imaging; 5) Sign the informed consent form and agree to join the patients in this study.

Exclusion criteria

Exclusion criteria: 1) Not meeting the diagnostic criteria for knee osteoarthritis; 2) K-L stage belongs to stage 0 or IV; 3) Uncontrolled joint infections, active joint tuberculosis, acute knee arthritis, rheumatoid arthritis, or local wounds; 4) Patients with meniscus or cruciate ligament injuries or other damages; 5) The affected limb has severe knee joint deformities, or is accompanied by severe vascular and neurological disorders or severe osteoporosis; 6) Have taken drugs that affect bone metabolism such as estrogen, steroid hormones, calcitonin, parathyroid hormone, bisphosphonates, fluoride, vitamin D, anticonvulsants, diuretics, etc. in the past 6 months; 7) Combined with severe primary type I diseases such as cardiovascular, cerebrovascular, and hematopoietic systems; 8) Combined with severe liver and kidney dysfunction; 9) Patients with mental illness or elderly dementia; 10) Allergic constitution, active period of gastrointestinal bleeding, ulcers, and perforation.

Design outcomes

Primary

MeasureTime frame
Vas;

Secondary

MeasureTime frame
EMG detection;Serum biochemical index detection;Western Ontario and McMaster Universities Arthritis Index;Traditional Chinese Medicine Efficacy Score;Ultrasound imaging indicators;

Countries

China

Contacts

Public ContactZhijun Hu

Longhua Hospital, Shanghai University of Traditional Chinese Medicine

hzjz1062@163.com+86 189 1776 3069

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Sep 6, 2026